Spots Global Cancer Trial Database for transfusion
Every month we try and update this database with for transfusion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS) | NCT02243124 | Myelodysplastic... | cenersen Dexamethasone | 18 Years - 95 Years | Eleos, Inc. | |
| Perioperative Management of Preoperative Anemia in Colorectal Cancer | NCT06026618 | Anemia Colorectal Canc... | 18 Years - | Consorci Sanitari Integral | ||
| AutoTransfusion Versus TRAnsfusion in Cancer Surgery | NCT05452538 | Hemorrhage Cancer Surgery Transfusion | Transfusion | 18 Years - | Centre Leon Berard | |
| A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy | NCT00216541 | Anemia Neoplasms | epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | NCT00270101 | Anemia Multiple Myelom... | epoetin alfa | 40 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | NCT00270127 | Anemia Cancer Neoplasm | Epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | NCT05957822 | Arthritis Knee Spine Fusion Prostate Cancer Arthritis of Hi... Hepatic Cancer | TXA TEG6 | 19 Years - | Konkuk University Medical Center | |
| Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | NCT05957822 | Arthritis Knee Spine Fusion Prostate Cancer Arthritis of Hi... Hepatic Cancer | TXA TEG6 | 19 Years - | Konkuk University Medical Center | |
| A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy | NCT00216541 | Anemia Neoplasms | epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | NCT00270101 | Anemia Multiple Myelom... | epoetin alfa | 40 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients | NCT05255445 | Sickle Cell Dis... Thalassemia Pediatric Cance... | Red Blood Cell ... | - | Westat | |
| A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM) | NCT04173494 | Primary Myelofi... Post-polycythem... Post-essential ... | Momelotinib Placebo to matc... Danazol Placebo to matc... | 18 Years - | Sierra Oncology LLC - a GSK company | |
| Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes | NCT00003138 | Anemia Myelodysplastic... | Erythropoietin Filgrastim Transfusion | 18 Years - | Eastern Cooperative Oncology Group | |
| Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy | NCT00270127 | Anemia Cancer Neoplasm | Epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma | NCT00270101 | Anemia Multiple Myelom... | epoetin alfa | 40 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| The Incidence of TRALI in Patients Undergoing Orthopedic-Oncology Surgery | NCT00914784 | Dyspnea Pulmonary Edema | 18 Years - 90 Years | Tel-Aviv Sourasky Medical Center | ||
| Argipressin's Influence on Blood Loss During Hepatic Resection | NCT05293041 | Colon Cancer Li... Inflammatory Re... Vasopressin Cau... | Argipressin Placebo | 18 Years - | Sahlgrenska University Hospital, Sweden | |
| Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR) | NCT05832450 | Brain Tumor Adu... Transfusion Surgery | Red cell concen... | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome | NCT03643042 | Myelodysplastic... Transfusion-dep... | Transfusion | 18 Years - | Lille Catholic University | |
| Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital | NCT05549232 | Hematologic Neo... Burns | Hypoxic Red Blo... | 18 Years - | Hemanext | |
| Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations | NCT01911871 | Thalassemia Sickle Cell Dis... Myelodysplasia | Blood sample | 6 Years - | Assistance Publique - Hôpitaux de Paris | |
| APG101 in Myelodysplastic Syndrome | NCT01736436 | Myelodysplastic... | Treatment with ... Bone marrow col... Blood drawings | 18 Years - | Apogenix AG | |
| A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy | NCT00283465 | Anemia Neoplasm | Epoetin alfa | 18 Years - | Janssen-Cilag B.V. | |
| Management of Preoperative Anaemia in Surgical Oncology | NCT05505006 | Anemia Tumor | Ferric Carboxym... Folic acid B12 | 18 Years - | Azienda Ospedaliera Universitaria Integrata Verona | |
| Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes | NCT00003138 | Anemia Myelodysplastic... | Erythropoietin Filgrastim Transfusion | 18 Years - | Eastern Cooperative Oncology Group | |
| Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01237639 | Hematologic Mal... | Red blood cell ... | 18 Years - | Ottawa Hospital Research Institute | |
| Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly | NCT02845232 | Acute Myeloid L... | Transfusion | 70 Years - | Hospices Civils de Lyon | |
| Management of Preoperative Anaemia in Surgical Oncology | NCT05505006 | Anemia Tumor | Ferric Carboxym... Folic acid B12 | 18 Years - | Azienda Ospedaliera Universitaria Integrata Verona | |
| UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies | NCT00578045 | Multiple Myelom... | Transfusion | 18 Years - | University of Arkansas | |
| Predictive Model to Calculate the Risk of RBC Transfusion in Elective Brain Tumours Resections (TScoreBTR) | NCT05832450 | Brain Tumor Adu... Transfusion Surgery | Red cell concen... | 18 Years - | Clinica Universidad de Navarra, Universidad de Navarra | |
| Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia | NCT01976442 | Leukemia, Myelo... Leukemia, Lymph... | - 50 Years | University of Rochester | ||
| AutoTransfusion Versus TRAnsfusion in Cancer Surgery | NCT05452538 | Hemorrhage Cancer Surgery Transfusion | Transfusion | 18 Years - | Centre Leon Berard | |
| A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT04419649 | Myelodysplastic... Cytopenia | KER-050 | 18 Years - | Keros Therapeutics, Inc. | |
| A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes | NCT04419649 | Myelodysplastic... Cytopenia | KER-050 | 18 Years - | Keros Therapeutics, Inc. | |
| APG101 in Myelodysplastic Syndrome | NCT01736436 | Myelodysplastic... | Treatment with ... Bone marrow col... Blood drawings | 18 Years - | Apogenix AG |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
